JPH07507568A - 有機保護活性を備えたペプチド - Google Patents
有機保護活性を備えたペプチドInfo
- Publication number
- JPH07507568A JPH07507568A JP6511727A JP51172794A JPH07507568A JP H07507568 A JPH07507568 A JP H07507568A JP 6511727 A JP6511727 A JP 6511727A JP 51172794 A JP51172794 A JP 51172794A JP H07507568 A JPH07507568 A JP H07507568A
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- seq
- disorders
- formula
- array
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Reproductive Health (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (13)
- 1.)8〜15個のアミノ酸残基を含み、これが一般式、【配列があります】 で表され、XaaがAla、bAla、Leu、Ile、Gly、Val、Nl e、Nvaのような中性脂肪アミノ酸残基を意味し、YaaがLys、Arg、 Orn、Hisのような塩基性アミノ酸残基を意味し、ZaaがGlu、Asp 、Aad又はAPmのような酸性アミノ酸残基を意味し、残基Xaa又はZaa の少なくとも1つが省略可能であることを特徴とする新しいクラスの生物学的に 高い活性のペプチド。
- 2.)分子が第1アミノ酸残基と最終アミノ酸残基との間のアミド結合によって 環化される請求項1に従うペプチド。
- 3.)Seq.Id.No:1の式、 【配列があります】 のペプチド。
- 4.)Seg.Id.No:2の式、 【配列があります】 のペプチド。
- 5.)Seq.Id.No:3の式、 【配列があります】 のペプチド。
- 6.)Seq.Id.No:4の式、 【配列があります】 のペプチド。
- 7.)Seq.Id.No:5の式、 【配列があります】 のペプチド。
- 8.)Seq.Id.No:6の式、 【配列があります】 のペプチド。
- 9.)Seq.Id.No:9の式、 【配列があります】 のペプチド。
- 10.)Seq.Id,No:10の式、【配列があります】 のペプチド。
- 11.)Seq.Id.No:11の式、【配列があります】 のペプチド。
- 12.)薬事的に許容できる固体又は液体媒介物との混合剤における請求項1〜 11に従う一又は複数の化合物を含有する治療構成物。
- 13.)ストレスで誘発された障害及び病気、肝臓及び膵臓の障害と病変、睾丸 の萎縮と精子易動性、受胎能力障害、商業的繁殖改良、リケッチア属の病気、甲 状腺上皮小体切除、真性糖尿病、副賢の障害、造血系の障害、凝固作用の障害、 出血の障害、去勢後/閉経の障害、虚血及び毒性病変、精神医学的障害、高血圧 症、体温の障害、苦痛、腫瘍、抑鬱症を処理するための請求項1〜11に従う新 規なペプチドの使用法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HR921283 | 1992-11-16 | ||
HR921283A | 1992-11-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07507568A true JPH07507568A (ja) | 1995-08-24 |
JP2812803B2 JP2812803B2 (ja) | 1998-10-22 |
Family
ID=10945833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6511727A Expired - Fee Related JP2812803B2 (ja) | 1992-11-16 | 1993-11-16 | 有機保護活性を備えたペプチド |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0624164B1 (ja) |
JP (1) | JP2812803B2 (ja) |
AT (1) | ATE163131T1 (ja) |
AU (1) | AU5624994A (ja) |
BG (1) | BG61697B1 (ja) |
CA (1) | CA2127553C (ja) |
CZ (1) | CZ285155B6 (ja) |
DE (1) | DE69316974T2 (ja) |
ES (1) | ES2114170T3 (ja) |
GR (1) | GR3026478T3 (ja) |
HU (3) | HUT67982A (ja) |
PL (1) | PL304666A1 (ja) |
RO (1) | RO115733B1 (ja) |
RU (1) | RU2116311C1 (ja) |
SI (1) | SI9300595B (ja) |
SK (1) | SK279227B6 (ja) |
WO (1) | WO1994011394A2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016513637A (ja) * | 2013-03-13 | 2016-05-16 | ダイアゲン デイ.オー.オー. | 新規安定性ペンタデカペプチド塩、その製造方法、医薬製剤の製造におけるその使用及び治療におけるその使用 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998052973A1 (en) * | 1997-05-23 | 1998-11-26 | Predrag Sikiric | New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU176089A (sh) * | 1989-09-12 | 1992-09-07 | Sikirić, Predrag | Postupak za pripremu supstancije bpc i supstancija bpc |
ATE152734T1 (de) * | 1992-05-30 | 1997-05-15 | Sikiric Predrag | Bpc-peptide, deren herstellung und verwendung |
-
1993
- 1993-11-16 HU HU9401952A patent/HUT67982A/hu unknown
- 1993-11-16 CA CA002127553A patent/CA2127553C/en not_active Expired - Fee Related
- 1993-11-16 WO PCT/EP1993/003217 patent/WO1994011394A2/en active IP Right Grant
- 1993-11-16 RO RO94-01091A patent/RO115733B1/ro unknown
- 1993-11-16 PL PL93304666A patent/PL304666A1/xx unknown
- 1993-11-16 DE DE69316974T patent/DE69316974T2/de not_active Expired - Lifetime
- 1993-11-16 CZ CZ941622A patent/CZ285155B6/cs not_active IP Right Cessation
- 1993-11-16 RU RU94037232A patent/RU2116311C1/ru not_active IP Right Cessation
- 1993-11-16 HU HU9303247A patent/HUT66303A/hu unknown
- 1993-11-16 AT AT94901809T patent/ATE163131T1/de active
- 1993-11-16 ES ES94901809T patent/ES2114170T3/es not_active Expired - Lifetime
- 1993-11-16 JP JP6511727A patent/JP2812803B2/ja not_active Expired - Fee Related
- 1993-11-16 SK SK857-94A patent/SK279227B6/sk not_active IP Right Cessation
- 1993-11-16 AU AU56249/94A patent/AU5624994A/en not_active Abandoned
- 1993-11-16 EP EP94901809A patent/EP0624164B1/en not_active Expired - Lifetime
- 1993-11-16 SI SI9300595A patent/SI9300595B/sl not_active IP Right Cessation
-
1994
- 1994-07-15 BG BG98907A patent/BG61697B1/bg unknown
-
1995
- 1995-06-21 HU HU95P/P00304P patent/HU211260A9/hu unknown
-
1998
- 1998-03-27 GR GR980400664T patent/GR3026478T3/el unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016513637A (ja) * | 2013-03-13 | 2016-05-16 | ダイアゲン デイ.オー.オー. | 新規安定性ペンタデカペプチド塩、その製造方法、医薬製剤の製造におけるその使用及び治療におけるその使用 |
Also Published As
Publication number | Publication date |
---|---|
BG98907A (bg) | 1995-05-31 |
HU9303247D0 (en) | 1994-03-28 |
CA2127553A1 (en) | 1994-05-26 |
SK85794A3 (en) | 1995-01-12 |
JP2812803B2 (ja) | 1998-10-22 |
GR3026478T3 (en) | 1998-06-30 |
DE69316974D1 (de) | 1998-03-19 |
RO115733B1 (ro) | 2000-05-30 |
AU5624994A (en) | 1994-06-08 |
EP0624164B1 (en) | 1998-02-11 |
RU94037232A (ru) | 1996-06-20 |
EP0624164A1 (en) | 1994-11-17 |
SI9300595B (sl) | 2003-04-30 |
CZ285155B6 (cs) | 1999-05-12 |
CZ162294A3 (en) | 1995-02-15 |
ES2114170T3 (es) | 1998-05-16 |
RU2116311C1 (ru) | 1998-07-27 |
ATE163131T1 (de) | 1998-02-15 |
SK279227B6 (sk) | 1998-08-05 |
HUT66303A (en) | 1994-11-28 |
DE69316974T2 (de) | 1998-07-16 |
PL304666A1 (en) | 1995-01-09 |
HU211260A9 (en) | 1995-11-28 |
HU9401952D0 (en) | 1994-09-28 |
CA2127553C (en) | 2003-01-28 |
HUT67982A (en) | 1995-05-29 |
WO1994011394A3 (en) | 1994-09-15 |
WO1994011394A2 (en) | 1994-05-26 |
SI9300595A (en) | 1994-09-30 |
BG61697B1 (bg) | 1998-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69133354T2 (de) | Interleukin 1-beta protease und ihre inhibitoren | |
JP3266311B2 (ja) | 新規ポリペプチドおよびこれを用いる抗hiv剤 | |
US6235716B1 (en) | Multivalent ligands which modulate angiogenesis | |
JP4006021B2 (ja) | ケモカインの生物学的活性の強化法 | |
EP1560590B1 (en) | Synthetic complementary peptides and ophthalmologic uses thereof | |
AU2006306974B2 (en) | New cyclic peptide compounds | |
JPH06504794A (ja) | 新規アミリン作動薬ペプチドおよびその使用 | |
JP2783681B2 (ja) | 有機保護活性を備えたペプチド | |
EP0564588B1 (en) | Hexapeptide anaphylatoxin-receptor ligands | |
NO177713B (no) | Analogifremgangsmåte ved fremstilling av hemoreguleringspeptider | |
KR20110093899A (ko) | 종양 괴사 인자 알파 억제 펩티드 및 이의 용도 | |
JP2020519623A (ja) | メトトレキサートとペプチドの結合体 | |
JPH02500269A (ja) | 新規テトラペプチド、その製法ならびにその用途 | |
JPH07507568A (ja) | 有機保護活性を備えたペプチド | |
KR102101339B1 (ko) | 피부질환 예방 또는 치료용 조성물 및 제조방법 | |
AU694701B2 (en) | Peptides with organo-protective activity, their preparation and use | |
JPH08505042A (ja) | レトロウイルス感染の阻害 | |
AU678917B2 (en) | Peptides with organo-protective activity, their preparation and use | |
JP3160013B2 (ja) | 新規ペプチド | |
WO2008050161A2 (en) | Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds | |
JPH07138289A (ja) | 新規なペプチド | |
NO175102B (no) | Analogifremgangsmåte for syntese av tetrapeptidet Ser-Asp-Lys-Pro-OH | |
JPS6341500A (ja) | ヒトインタ−フエロン−α誘導体 | |
JPS59501985A (ja) | 生殖腺機能に影響を及ぼすペプチド類 | |
WO1984002130A1 (en) | Novel polypeptides and their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070807 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080807 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080807 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090807 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090807 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100807 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110807 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110807 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120807 Year of fee payment: 14 |
|
LAPS | Cancellation because of no payment of annual fees |